Pierre Fabre Medicament News
Most Popular Pierre Fabre Medicament Story
Abbott pays $25M upfront for Pierre Fabre cancer pact
Wooed by the prospects of one of Pierre Fabre's promising pre-clinical cancer programs, Abbott Laboratories has agreed to pay the French biotech $25 million upfront, two years of research expenses Read more...
Latest Headlines
- January 20, 2011
- February 2, 2010
- December 22, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
